Aviva’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $203M | Buy |
404,389
+20,387
| +5% | +$9.79M | 0.3% | 64 |
|
|
2026
Q1 | $189M | Sell |
384,002
-22,163
| -5% | -$12M | 0.32% | 57 |
|
|
2025
Q4 | $235M | Sell |
406,165
-15,042
| -4% | -$8.51M | 0.4% | 39 |
|
|
2025
Q3 | $204M | Sell |
421,207
-4,895
| -1% | -$2.28M | 0.37% | 42 |
|
|
2025
Q2 | $173M | Buy |
426,102
+157,889
| +59% | +$66M | 0.36% | 45 |
|
|
2025
Q1 | $133M | Buy |
268,213
+25,951
| +11% | +$14.1M | 0.32% | 57 |
|
|
2024
Q4 | $126M | Sell |
242,262
-54,873
| -18% | -$30.2M | 0.33% | 51 |
|
|
2024
Q3 | $184M | Sell |
297,135
-57
| -0% | -$33.7K | 0.48% | 35 |
|
|
2024
Q2 | $164M | Buy |
297,192
+28,430
| +11% | +$16.3M | 0.46% | 33 |
|
|
2024
Q1 | $156M | Sell |
268,762
-5,419
| -2% | -$3.04M | 0.51% | 31 |
|
|
2023
Q4 | $146M | Sell |
274,181
-18,762
| -6% | -$9.08M | 0.52% | 33 |
|
|
2023
Q3 | $148M | Sell |
292,943
-39,431
| -12% | -$21M | 0.62% | 30 |
|
|
2023
Q2 | $173M | Buy |
332,374
+119,428
| +56% | +$64.4M | 0.71% | 26 |
|
|
2023
Q1 | $123M | Sell |
212,946
-19,830
| -9% | -$11.2M | 0.56% | 19 |
|
|
2022
Q4 | $128M | Buy |
232,776
+35,603
| +18% | +$18.9M | 0.63% | 20 |
|
|
2022
Q3 | $100M | Sell |
197,173
-1,018
| -0.5% | -$570K | 0.58% | 17 |
|
|
2022
Q2 | $108M | Buy |
198,191
+9,230
| +5% | +$5.08M | 0.57% | 21 |
|
|
2022
Q1 | $112M | Sell |
188,961
-62,266
| -25% | -$35.8M | 0.56% | 25 |
|
|
2021
Q4 | $168M | Buy |
251,227
+10,720
| +4% | +$6.69M | 0.7% | 21 |
|
|
2021
Q3 | $137M | Sell |
240,507
-933
| -0.4% | -$512K | 0.61% | 28 |
|
|
2021
Q2 | $122M | Sell |
241,440
-25,658
| -10% | -$12.1M | 0.53% | 32 |
|
|
2021
Q1 | $122M | Sell |
267,098
-43,567
| -14% | -$20.8M | 0.6% | 29 |
|
|
2020
Q4 | $145M | Sell |
310,665
-1,262
| -0.4% | -$592K | 0.75% | 21 |
|
|
2020
Q3 | $138M | Sell |
311,927
-8,258
| -3% | -$3.41M | 0.81% | 21 |
|
|
2020
Q2 | $116M | Sell |
320,185
-53,240
| -14% | -$17.8M | 0.72% | 26 |
|
|
2020
Q1 | $106M | Sell |
373,425
-4,778
| -1% | -$1.51M | 0.78% | 20 |
|
|
2019
Q4 | $123M | Buy |
378,203
+9,191
| +2% | +$2.79M | 0.74% | 25 |
|
|
2019
Q3 | $107M | Buy |
369,012
+48,483
| +15% | +$13.9M | 0.73% | 30 |
|
|
2019
Q2 | $94.1M | Buy |
320,529
+35,910
| +13% | +$9.89M | 0.65% | 33 |
|
|
2019
Q1 | $77.9M | Buy |
284,619
+284
| +0.1% | +$70.7K | 0.52% | 48 |
|
|
2018
Q4 | $63.6M | Sell |
284,335
-21,293
| -7% | -$5M | 0.47% | 50 |
|
|
2018
Q3 | $74.6M | Sell |
305,628
-9,585
| -3% | -$2.21M | 0.41% | 62 |
|
|
2018
Q2 | $65.3M | Buy |
315,213
+47,953
| +18% | +$10.2M | 0.39% | 61 |
|
|
2018
Q1 | $55.2M | Sell |
267,260
-18,556
| -6% | -$3.89M | 0.34% | 76 |
|
|
2017
Q4 | $54.3M | Sell |
285,816
-28,797
| -9% | -$5.52M | 0.31% | 79 |
|
|
2017
Q3 | $59.5M | Buy |
314,613
+6,939
| +2% | +$1.26M | 0.32% | 73 |
|
|
2017
Q2 | $53.7M | Buy |
307,674
+820
| +0.3% | +$138K | 0.3% | 74 |
|
|
2017
Q1 | $47.1M | Sell |
306,854
-13,894
| -4% | -$2.12M | 0.27% | 91 |
|
|
2016
Q4 | $45.3M | Buy |
320,748
+39,568
| +14% | +$5.83M | 0.27% | 87 |
|
|
2016
Q3 | $44.7M | Buy |
281,180
+17,495
| +7% | +$2.7M | 0.28% | 83 |
|
|
2016
Q2 | $39M | Buy |
263,685
+41,827
| +19% | +$6.17M | 0.27% | 85 |
|
|
2016
Q1 | $31.4M | Buy |
221,858
+3,755
| +2% | +$503K | 0.23% | 94 |
|
|
2015
Q4 | $30.9M | Sell |
218,103
-1,377
| -0.6% | -$184K | 0.23% | 94 |
|
|
2015
Q3 | $26.8M | Sell |
219,480
-4,754
| -2% | -$619K | 0.22% | 107 |
|
|
2015
Q2 | $29.1M | Buy |
224,234
+11,070
| +5% | +$1.44M | 0.21% | 117 |
|
|
2015
Q1 | $28.6M | Buy |
213,164
+49,361
| +30% | +$6.36M | 0.2% | 116 |
|
|
2014
Q4 | $20.5M | Sell |
163,803
-470
| -0.3% | -$57.1K | 0.16% | 151 |
|
|
2014
Q3 | $20M | Buy |
164,273
+870
| +0.5% | +$106K | 0.16% | 152 |
|
|
2014
Q2 | $19.3M | Buy |
163,403
+560
| +0.3% | +$65.9K | 0.15% | 172 |
|
|
2014
Q1 | $19.6M | Buy |
162,843
+20,360
| +14% | +$2.42M | 0.16% | 159 |
|
|
2013
Q4 | $15.9M | Buy |
142,483
+5,423
| +4% | +$539K | 0.13% | 186 |
|
|
2013
Q3 | $12.6M | Buy |
137,060
+27,679
| +25% | +$2.5M | 0.11% | 220 |
|
|
2013
Q2 | $9.26M | Buy |
+109,381
| New | +$9.11M | 0.09% | 246 |
|
Other funds holding TMO
Aviva's TMO Position: Q2 2026 in Review
Aviva increased its Thermo Fisher Scientific (TMO) stake by 5.3% in Q2 2026, buying an estimated $9.79M and bringing the position to 404,389 shares worth $203M. The position accounts for 0.3% of the portfolio, ranked #64.
Aviva first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $235M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Aviva held 404,389 shares of Thermo Fisher Scientific worth $203M as of Q2 2026.
- Aviva bought 20,387 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.79M.
- Thermo Fisher Scientific made up 0.3% of Aviva's portfolio in Q2 2026, its #64 holding.
- Aviva first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Aviva's Thermo Fisher Scientific position peaked at $235M in Q4 2025.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.